0 items USD 0.00Search
- Did you mean
- closing spondylitis
Your search for "Ankylosing%20spondylitis" gave back 192 results.
Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Highlights The global Arthritic Therapeutic market was valued at US$ 28340 million in 2022 and is anticipated to reach US$ 35210 million by 2029,...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Dexibuprofen is a nonsteroidal anti-inflammatory drug. It is the active dextrorotatory enantiomer of ibuprofen. Most ibuprofen formulations contain a...
Catalog:
GIR
January 2023
Price: USD 3,480.00
The global Etoricoxib Intermediate market size was valued at US$ million in 2023. With growing demand in downstream market, the Etoricoxib...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Autoimmune Drugs market size was valued at US$ 2193.5 million in 2023. With growing demand in downstream market, the Autoimmune Drugs is...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Rheumatology Therapeutics market size was valued at US$ 45350 million in 2023. With growing demand in downstream market, the Rheumatology...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Infliximab and Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Infliximab and...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Arthritic Therapeutic market was valued at US$ 27240 million in 2023 and is anticipated to reach US$ 35210 million by 2030, witnessing a...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that explicitly targets enzymes responsible for inflammation and pain namely...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The Musculoskeletal Disorders Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global PDE 4 Inhibitors market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of %...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global JAK1 Inhibitors market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of %...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Humira Biosimilar market size is expected to reach $ 955.4 million by 2029, rising at a market growth of 12.0% CAGR during the forecast...
Catalog:
GIR
June 2023
Price: USD 4,480.00
